Salpingectomy for the Primary Prevention of Ovarian Cancer
Authors:
Top Cited Papers
- 1 November 2023
- journal article
- review article
- Published by American Medical Association (AMA) in JAMA Surgery
- Vol. 158 (11) , 1204-1211
Abstract
Importance: Most ovarian cancers originate in the fimbriated end of the fallopian tube. This has led to the hypothesis that surgical resection of the fallopian tubes at the time of gynecologic and nongynecologic surgical procedures—referred to as an opportunistic salpingectomy—may prevent the development of epithelial ovarian cancer for women at an average risk of developing the disease. Objective: To compile a comprehensive, state-of-the-science review examining the current landscape of performing bilateral salpingectomy for ovarian cancer prevention. Evidence Review: A systematic review of the literature was performed on March 4, 2022, to identify studies examining salpingectomy for ovarian cancer prevention. This review was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) 2020 statement. Four databases were selected: PubMed via the National Library of Medicine’s PubMed.gov, Embase via Elsevier’s Embase.com, Cochrane Central Register of Controlled Trials (CENTRAL) via Wiley’s Cochrane Library, and Northern Light Life Sciences Conference Abstracts via Ovid. A total of 20 gray literature sources, including 1 database, 2 registers, 1 repository, 1 index, 1 archive, 1 preprint server, 1 agency, and 12 organizations, were also searched. Findings: The initial search produced 1089 results; a total of 158 publications were included in the final review. Salpingectomy has been associated with ovarian cancer risk reduction of approximately 80%. Studies have demonstrated that salpingectomy was safe, cost-effective, and was not associated with an earlier age of menopause onset. With widespread implementation, salpingectomy has the potential to reduce ovarian cancer mortality in the US by an estimated 15%. Both physician and patient awareness regarding the adnexa as the origin for most ovarian cancers, as well as the existence of salpingectomy and its potential benefits in reducing ovarian cancer risk, has increased during the past decade. Raising awareness and developing effective implementation strategies are essential. Conclusions and Relevance: The results of this systematic review suggest that bilateral salpingectomy for ovarian cancer prevention was safe and feasible and has the potential to be a cost-effective and cost-saving strategy across the population. Prospective studies to demonstrate long-term survival outcomes and feasibility in nongynecologic surgical procedures are warranted.Keywords
This publication has 62 references indexed in Scilit:
- Opportunistic and interventional salpingectomy in women at risk: a strategy for preventing pelvic serous cancer (PSC)European Journal of Obstetrics & Gynecology and Reproductive Biology, 2013
- Physician Opinions Regarding Elective Bilateral Salpingectomy With Hysterectomy and for SterilizationJournal of Minimally Invasive Gynecology, 2013
- Salpingectomy to Prevent Ovarian CancerCurrent Oncology, 2013
- Fallopian Tube Removal: “stic-Ing” it to Ovarian Cancer: What Is the Utility of Prophylactic Tubal Removal?Current Oncology, 2013
- Prophylactic salpingectomy in premenopausal low-risk women for ovarian cancer: Primum non nocereGynecologic Oncology, 2013
- Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer—Shifting the paradigmHuman Pathology, 2011
- Are All Pelvic (Nonuterine) Serous Carcinomas of Tubal Origin?American Journal of Surgical Pathology, 2010
- The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying TheoryAmerican Journal of Surgical Pathology, 2010
- The Fallopian Tube: Primary Site of Most Pelvic High-grade Serous CarcinomasInternational Journal of Gynecological Cancer, 2009
- Intraepithelial Carcinoma of the Fimbria and Pelvic Serous Carcinoma: Evidence for a Causal RelationshipAmerican Journal of Surgical Pathology, 2007